A 51-year-old man was referred to gastroenterology for screening colonoscopy.
Family history includes pancreatic cancer on his father’s side and pre-menopausal breast cancer in his aunt.
Colonoscopy revealed a 3-cm mass, proximal to the hepatic flexure.
Biopsy confirmed the lesion to be of adenocarcinoma histology.
At the time, the patient underwent right hemicolectomy revealing a moderately differentiated tumor. Fifteen lymph nodes were removed and tested negative for metastatic disease, denoting stage T3N0M0 colon cancer.
The patient healed without complications and received no further treatment.
April 2015
The patient continued to feel well, except for occasional fatigue and diarrhea.
PET/CT scan revealed several small lesions in multiple lobes of the liver that were PET avid
Biopsy was performed and confirmed the liver lesions to be metastases from colon cancer
The patient was referred to a local oncologist and started on infusional 5-FU and oxaliplatin (FOLFOX) in combination with bevacizumab.
CT scan 2 months after starting treatment showed a partial response to therapy; at 4 months the patients tumor continued to shrink
Oxaliplatin was discontinued; subsequently the patient received maintenance therapy with capecitabine and bevacizumab, resulting in continued disease control
February 27, 2017
The patient has had stable disease for 22 months and remains on bevacizumab maintenance therapy.
He appears generally well and free of symptoms.
Newsletter
Stay up to date on practice-changing data in community practice.